Celgene (CELG +0.9%) finishes the day in the positive after U.S. regulators approved its...

|About: Celgene Corporation (CELG)|By:, SA News Editor

Celgene (CELG +0.9%) finishes the day in the positive after U.S. regulators approved its Abraxana medication, a first-line treatment of advanced non-small cell lung cancer in patients not being treated surgically or with radiation therapy.